Recognizing the development of microbicides as an important priority in HIV/AIDS research, the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), established the Microbicide Trials Network (MTN) in 2006 as its newest of six NIAID-funded HIV/AIDS clinical trials networks. The MTN brings together international investigators and community and industry partners who are devoted to reducing the sexual transmission of HIV through the development and evaluation of products applied topically or administered orally, working within a unique infrastructure specifically designed to facilitate research required to support licensure of these products for widespread use.
What We Do
Sharon Hillier, PhD, Principal Investigator
Ian McGowan, MD, PhD, Co-Principal Investigator
Connie Celum, MD, MPH, Co-Principal Investigator
Charlene Dezzutti, PhD, Laboratory Principal Investigator
Benoit Masse, PhD, Statistical and Data Management Center Principal Investigator
Ward Cates, MD, Family Health International Principal Investigator